spike
protein
sever
acut
respiratori
syndrom
sar
coronaviru
cov
type
transmembran
envelop
glycoprotein
consist
domain
respons
viru
bind
fusion
respect
contain
receptorbind
domain
rbd
specif
bind
angiotensinconvert
enzym
receptor
target
cell
show
recombin
fusion
protein
design
rbdfc
contain
acid
rbd
residu
human
fc
fragment
induc
highli
potent
antibodi
respons
immun
rabbit
antibodi
recogn
rbd
domain
complet
inhibit
sarscov
infect
serum
dilut
rabbit
antisera
effect
block
bind
contain
rbd
suggest
rbd
induc
highli
potent
neutral
antibodi
respons
potenti
develop
effect
safe
subunit
vaccin
prevent
sar
sever
acut
respiratori
syndrom
sar
newli
emerg
infecti
diseas
caus
sarsassoci
coronaviru
sarscov
may
origin
wild
anim
global
outbreak
sar
result
thousand
case
hundr
death
serious
threaten
public
health
worldwid
earli
new
infect
caus
sarscov
strain
differ
predomin
last
outbreak
report
china
latest
sar
outbreak
report
beij
anhui
provinc
china
april
incomplet
inactiv
viru
use
laboratori
center
diseas
control
china
may
major
caus
outbreak
http
wwwwhointcsrsarsen
indic
sar
epidem
may
recur
time
futur
therefor
develop
effect
safe
vaccin
urgent
need
protect
atrisk
popul
current
one
candid
vaccin
use
inactiv
sarscov
phase
clinic
trial
china
although
inactiv
sarscov
may
effect
protect
anim
challeng
sarscov
efficaci
human
unclear
seriou
concern
safeti
sinc
antigen
virion
may
elicit
antibodi
neutral
see
front
matter
elsevi
inc
right
reserv
rather
enhanc
viru
infect
viral
protein
may
induc
harm
immun
inflammatori
respons
potenti
caus
sar
pathogenesi
recent
report
sarscov
infect
ferret
caus
mild
liver
inflamm
liver
damag
becam
much
seriou
ferret
first
immun
vaccinia
virusbas
sar
vaccin
viru
challeng
protein
coronavirus
respons
viru
bind
fusion
entri
major
induc
neutral
antibodi
besid
play
critic
role
viral
pathogenesi
virul
protein
sarscov
also
import
viral
function
antigen
type
transmembran
glycoprotein
consist
two
domain
fig
respons
viru
bind
receptor
target
cell
demonstr
angiotensinconvert
enzym
function
receptor
sarscov
fragment
locat
middl
region
receptorbind
domain
rbd
domain
contain
put
fusion
peptid
two
heptad
repeat
region
fig
respons
fusion
viral
target
cell
membran
like
antihiv
peptid
deriv
region
peptid
deriv
region
sarscov
protein
inhibitori
activ
sarscov
infect
region
associ
form
sixhelix
bundl
structur
resembl
fusionact
core
structur
hiv
protein
coronavirus
mous
hepat
coronaviru
mhv
suggest
upon
bind
rbd
viral
protein
target
cell
chang
conform
interact
region
form
fusogen
core
bring
viral
target
cell
membran
close
proxim
result
viru
fusion
entri
indic
fragment
contain
function
domain
protein
may
use
antigen
induc
antibodi
block
viru
bind
fusion
sever
live
attenu
genet
engin
vector
vaccin
encod
sarscov
protein
preclin
studi
nabel
cowork
report
dna
vaccin
candid
encod
protein
induc
tcell
neutralizingantibodi
respons
neutral
antibodi
titer
rang
protect
mice
sarscov
challeng
shown
reduc
titer
sarscov
respiratori
tract
prove
protect
mediat
neutral
antibodi
tcelldepend
mechan
moss
cowork
demonstr
intranas
intramuscular
inocul
mice
highli
attenu
modifi
vaccinia
viru
vector
viru
ankara
mva
contain
gene
encod
fulllength
sarscov
protein
mva
produc
sspecif
antibodi
sarscovneutr
activ
mean
neutral
titer
protect
mice
sarscov
infect
transfer
serum
immun
mice
recent
collin
cowork
report
mucos
immun
african
green
monkey
attenu
parainfluenza
viru
express
sarscov
protein
result
product
neutral
antibodi
mean
neutral
titer
protect
anim
challeng
infect
data
suggest
protein
induc
protect
neutral
antibodi
although
neutral
antibodi
titer
rel
low
report
recombin
fusion
protein
contain
rbd
sarscov
protein
residu
link
human
fc
fragment
design
rbdfc
see
fig
induc
high
titer
rbdspecif
antibodi
immun
rabbit
rabbit
antisera
effect
inhibit
bind
protein
potent
neutral
sarscov
sar
pseudoviru
suggest
rbd
protein
may
develop
subunit
vaccin
prevent
sar
fig
schemat
diagram
sarcov
protein
recombin
fusion
protein
rbdfc
protein
consist
domain
signal
peptid
sp
locat
nterminu
protein
domain
contain
receptorbind
domain
rbd
domain
contain
cytoplasm
domain
cp
transmembran
domain
tm
ectodomain
compos
put
intern
fusion
peptid
fp
heptad
repeat
region
rbdfc
consist
rbd
human
iggfc
fragment
contain
protein
domain
fragment
express
recombin
rbdfc
protein
plasmid
encod
fragment
sarscov
protein
residu
correspond
receptorbind
domain
fuse
fc
domain
human
rbdfc
plasmid
encod
protein
residu
tag
cterminu
describ
previous
rbdfc
protein
express
transfect
cell
plasmid
use
fugen
reagent
boehringermannheim
indianapoli
accord
protocol
supernat
harvest
h
posttransfect
recombin
rbdfc
fusion
protein
purifi
protein
asepharos
fast
flow
amersham
bioscienc
piscataway
nj
protein
purifi
affin
chromatographi
mous
monoclon
antibodi
mab
nation
cell
cultur
center
minneapoli
mn
immun
rabbit
two
nzw
rabbit
immun
intraderm
lg
purifi
rbdfc
resuspend
phosphatebuff
solut
pb
ph
presenc
complet
adjuv
fca
boost
three
time
freshli
prepar
emuls
lg
immunogen
incomplet
adjuv
fia
interv
preimmun
sera
collect
start
immun
antisera
collect
day
boost
sera
kept
use
enzymelink
immunosorb
assay
reactiv
rabbit
sera
variou
antigen
determin
enzymelink
immunosorb
assay
elisa
briefli
lgml
recombin
protein
rbdfc
purifi
human
igg
zyme
south
san
francisco
ca
use
respect
coat
microtit
plate
corn
costar
acton
carbon
buffer
ph
overnight
block
nonfat
milk
serial
dilut
rabbit
sera
ad
incub
h
follow
four
wash
pb
contain
tween
bound
antibodi
detect
hrpconjug
goat
antirabbit
igg
zyme
h
follow
wash
reaction
visual
addit
substrat
tetramethylbenzidin
tmb
absorb
nm
measur
elisa
plate
reader
tecan
us
research
triangl
park
nc
immunoabsorpt
assay
antihuman
iggfc
rabbit
antisera
deplet
immunoabsorpt
briefli
immunoaffin
resin
prepar
coupl
human
igg
zyme
cyanogen
bromideactiv
sepharos
bead
pharmacia
piscataway
nj
accord
instruct
immunoabsorpt
perform
dilut
rabbit
antisera
pb
incub
human
igg
resin
overnight
constant
rotat
resin
pack
column
flowthrough
antifc
deplet
antisera
collect
neutral
sarscov
infect
neutral
sarscov
infect
assess
previous
describ
briefli
vero
cell
plate
cellswel
tissu
cultur
plate
grown
overnight
one
hundr
tcid
tissuecultur
infecti
dose
sarscov
strain
genbank
access
mix
equal
volum
dilut
rabbit
sera
incub
h
mixtur
ad
monolay
vero
cell
cytopath
effect
cpe
record
day
postinfect
previous
describ
neutral
titer
repres
dilut
rabbit
antisera
complet
prevent
cpe
well
calcul
reedmeunch
method
neutral
pseudoviru
infect
sensit
quantit
safe
neutral
assay
base
report
sarscov
pseudoviru
system
develop
hiv
pseudotyp
sarscov
protein
prepar
previous
describ
brief
cell
cotransfect
plasmid
encod
codonoptim
sarscov
protein
plasmid
encod
envdefect
luciferaseexpress
genom
use
fugen
reagent
boehringermannheim
supernat
contain
hivsarscov
protein
harvest
h
posttransfect
use
singlecycl
infect
cell
briefli
cell
plate
cellswel
tissuecultur
plate
grown
overnight
pseudoviru
preincub
serial
dilut
rabbit
sera
h
addit
cell
cultur
refe
fresh
medium
h
later
incub
addit
h
cell
wash
pb
lyse
use
lysi
reagent
includ
luciferas
kit
promega
madison
wi
aliquot
cell
lysat
transfer
costar
flatbottom
luminomet
plate
corn
costar
corn
ny
follow
addit
luciferas
substrat
promega
rel
light
unit
determin
immedi
ultra
luminomet
tecan
us
inhibit
bind
solubl
recombin
solubl
r
system
minneapoli
mn
lgml
coat
elisa
plate
corn
costar
carbon
buffer
ph
overnight
block
nonfat
milk
lgml
ad
well
presenc
absenc
serial
dilut
rabbit
sera
incub
h
mab
ad
incub
addit
h
wash
hrpconjug
goat
antimous
igg
zyme
substrat
tmb
use
detect
measur
inhibit
bind
cellexpress
flow
cytometri
stabl
cell
detach
wash
balanc
salt
solut
hbss
sigma
st
loui
mo
ad
cell
final
concentr
lgml
presenc
absenc
rabbit
sera
indic
dilut
follow
incub
room
temperatur
min
thorough
wash
mab
ad
cell
final
concentr
lg
ml
incub
room
temperatur
min
cell
wash
hbss
incub
antimous
iggfitc
conjug
sigma
dilut
room
temperatur
addit
min
wash
cell
fix
formaldehyd
pb
analyz
becton
facscalibur
flow
cytomet
mountain
view
ca
use
cellquest
softwar
rabbit
antisera
collect
immun
preimmun
day
boost
interv
week
serum
sampl
dilut
test
bind
recombin
fusion
protein
rbdfc
elisa
shown
fig
antisera
collect
day
boost
maximum
reactiv
rbdfc
retain
high
level
boost
mean
endpoint
titer
antisera
collect
boost
fig
therefor
use
antisera
sampl
subsequ
experi
sinc
rbdfc
also
contain
human
iggfc
fragment
antibodi
rabbit
sera
may
also
bind
fc
addit
rbd
therefor
test
bind
activ
rabbit
antisera
recombin
protein
contain
rbd
fc
shown
fig
rabbit
antisera
bound
pattern
similar
shown
experi
use
rbdfc
antigen
shown
fig
b
although
reactiv
titer
antibodi
lower
rbdfc
suggest
antirbd
antibodi
one
major
antibodi
popul
rabbit
antisera
rabbit
antisera
test
neutral
activ
use
two
differ
assay
system
ie
infect
sarscov
vero
sar
pseudoviru
cell
express
shown
fig
rabbit
antisera
boost
lower
dilut
fulli
protect
vero
cell
sarscov
infect
ie
cpe
seen
cell
monolay
remain
intact
higher
serum
dilut
cell
number
decreas
due
cpe
mediat
sarscov
replic
cell
mean
neutral
antibodi
titer
calcul
base
reedmeunch
method
preimmun
rabbit
sera
dilut
inhibitori
activ
sarscov
infect
antirbd
antisera
rabbit
b
also
highli
effect
inhibit
infect
sar
pseudoviru
neutral
titer
respect
fig
suggest
antirbd
antibodi
inhibit
infect
sarscov
sar
pseudoviru
rabbit
antisera
boost
possess
compar
neutral
activ
sar
viru
data
shown
deplet
antifc
antibodi
antisera
direct
rbdfc
affect
rbdbind
neutral
activ
sinc
recombin
fusion
protein
rbdfc
also
contain
human
iggfc
fragment
expect
antigen
also
induc
antifc
antibodi
inde
rabbit
antisera
react
human
iggfc
coat
well
plate
fig
howev
antifc
antibodi
could
deplet
antisera
immunoabsorpt
sinc
antifcdeplet
antisera
reaction
human
igg
elisa
fig
antifcdeplet
antisera
retain
rbdbind
activ
fig
neutral
activ
fig
compar
untreat
rabbit
antisera
result
suggest
antifc
antibodi
antisera
induc
human
iggfc
contribut
rbdbind
virusneutr
activ
rabbit
antisera
fig
rabbit
antisera
contain
high
titer
antibodi
bind
rbd
bind
rbdfc
antisera
collect
rabbit
immun
preimmun
day
boost
b
bind
rbdfc
rabbit
antisera
collect
day
first
boost
seri
dilut
c
bind
antisera
collect
rabbit
immun
preimmun
day
boost
bind
protein
rabbit
antisera
collect
day
first
boost
seri
dilut
sampl
test
duplic
data
present
mean
valu
two
test
follow
figur
test
whether
antirbd
antibodi
block
rbd
bind
solubl
cellassoci
use
elisa
flow
cytometri
respect
sinc
rbdfc
also
react
antifc
antibodi
antisera
direct
rbdfc
use
contain
rbd
fc
experi
determin
bind
rbd
elisa
solubl
coat
well
elisa
plate
abl
bind
data
shown
rabbit
antirbd
antisera
effect
block
bind
dosedepend
manner
preimmun
sera
inhibitori
activ
fig
solubl
coat
plastic
may
lose
nativ
conform
also
use
cell
express
expect
retain
nativ
conform
detect
rbdbind
activ
flowcytometr
assay
shown
fig
significantli
bound
cell
measur
use
mab
posit
control
ad
neg
control
background
signal
detect
rabbit
antisera
effect
block
bind
cell
preimmun
rabbit
sera
dilut
inhibitori
activ
fig
inhibitori
activ
rabbit
antisera
bind
cell
dosedepend
deplet
antifc
antibodi
rabbit
antisera
affect
inhibitori
activ
rabbit
antisera
interact
fig
confirm
antirbd
activ
mediat
antifc
antibodi
sar
pandem
despit
lack
effect
specif
therapi
sar
patient
recov
acut
ill
reinfect
sarscov
http
wwwwhointcsrsar
en
neutral
antibodi
detect
convalesc
sera
sar
patient
inocul
hyperimmun
sera
mice
infect
sarscov
immun
mva
mice
administr
neutral
monoclon
antibodi
ferret
reduc
titer
sarscov
respiratori
tract
anim
challeng
data
suggest
protect
humor
immun
achiev
vaccin
develop
prevent
sar
number
vaccin
candid
preclin
studi
includ
inactiv
vaccin
dna
vaccin
attenu
virus
encod
sarscov
protein
agent
effect
induc
protect
neutralizingantibodi
respons
anim
present
studi
use
recombin
fusion
protein
rbdfc
immunogen
immun
rabbit
sinc
rbd
key
function
domain
protein
respons
viral
bind
receptor
target
cell
contain
neutral
epitop
antibodi
rbd
protein
fig
effect
deplet
human
iggfc
specif
antibodi
rabbit
antisera
bind
virusneutr
activ
bind
activ
antifcdeplet
untreat
rabbit
antisera
human
igg
b
test
dilut
elisa
neutral
activ
antifcdeplet
rabbit
antisera
hivsarscov
compar
untreat
rabbit
antisera
c
fig
rabbit
antisera
inhibit
bind
inhibit
bind
solubl
rabbit
antisera
measur
elisa
b
inhibit
bind
cellexpress
rabbit
antisera
measur
flow
cytometri
posit
control
rabbit
serum
ad
neg
control
neither
rabbit
serum
ad
c
rabbit
antisera
inhibit
bind
cell
dosedepend
manner
coronavirus
mhv
transmiss
gastroenter
viru
tgev
human
coronaviru
receptor
coronavirus
highli
effect
block
rbdreceptor
interact
neutral
infect
correspond
coronavirus
found
rbdfc
fusion
protein
elicit
robust
antibodi
respons
immun
rabbit
rabbit
antisera
could
complet
block
sarscov
infect
serum
dilut
fig
sinc
fulllength
protein
contain
rbd
viral
function
domain
multipl
neutral
epitop
expect
induc
potent
neutral
antibodi
rbd
alon
one
possibl
reason
rbd
actual
elicit
much
higher
titer
neutral
antibodi
fulllength
protein
latter
contain
nonneutr
epitop
may
elicit
enhanc
antibodi
like
induc
antigen
site
envelop
glycoprotein
hiv
ebola
viru
protein
coronavirus
could
also
induc
enhanc
antibodi
exampl
immun
felin
vaccinia
viru
vector
encod
protein
felin
infecti
periton
viru
fipv
result
enhanc
viru
replic
viru
challeng
epitop
elicit
enhanc
antibodi
local
protein
although
enhanc
viru
replic
may
observ
may
exclud
possibl
enhanc
antibodi
titer
lower
neutral
antibodi
titer
case
enhanc
antibodi
may
suppress
neutral
neutralizingantibodi
activ
result
reduc
neutralizingantibodi
titer
rabbit
antisera
direct
rbd
effect
bind
rbd
domain
sarscov
protein
fig
block
rbd
bind
solubl
cellexpress
fig
confirm
rabbit
antisera
contain
antibodi
specif
target
rbd
although
test
protect
activ
rabbit
antirbd
antibodi
anim
model
sarscov
challeng
high
neutral
titer
antisera
test
vitro
suggest
rbdfc
may
induc
strong
protect
immun
anim
human
consid
effect
protect
sarscov
infect
achiev
convalesc
sera
sar
patient
neutral
antibodi
titer
rang
antisera
mice
monkey
immun
dna
vaccin
attenu
virus
encod
protein
respect
low
neutral
antibodi
titer
sequenc
protein
especi
domain
coronavirus
highli
variabl
major
concern
develop
effect
vaccin
viru
strain
distinct
genotyp
phenotyp
howev
recent
studi
shown
sarscov
strain
quit
stabl
chang
much
origin
predict
earli
phase
sar
endem
amino
acid
residu
rbd
sarscov
protein
variabl
due
posit
select
pressur
process
transit
anim
eg
palm
civet
sarslikecov
human
sarscov
howev
middl
late
phase
viru
strain
isol
sar
patient
two
phase
mutat
rbd
sequenc
furthermor
conform
rbd
rel
conserv
ensur
bind
viru
differ
subtyp
specif
receptor
target
cell
even
though
linear
sequenc
rbd
may
variabl
one
exampl
mab
recogn
neutral
epitop
domain
neutral
broad
rang
primari
isol
although
linear
sequenc
region
correspond
strain
highli
variabl
suggest
antiantibodi
conserv
rbd
protein
may
neutral
activ
broad
spectrum
sarscov
strain
summari
rbd
protein
potenti
develop
subunit
vaccin
sinc
induc
highli
potent
antibodi
block
protein
bind
receptor
neutral
sarscov
infect
low
level
risk
compar
inactiv
virus
live
attenu
viru
vector
